Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

被引：0
|
作者：
Brian R. Ott
Lesley M. Blake
Ethel Kagan
Malca Resnick
机构：
[1] Rhode Island Hospital – APC 6,The Alzheimer’s Disease & Memory Disorders Center
[2] Northwestern University,Department of Psychiatry
[3] Harborside Financial Center,Forest Laboratories, Inc.
来源：
Journal of Neurology | 2007年 / 254卷
关键词：
Alzheimer’s disease; memantine; open label; randomized controlled trial; ADAS-cog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 358
页数：7
相关论文
共 50 条
  • [41] Efficacy of memantine on cognition in mild to moderate Alzheimer's disease
    Pomara, Nunzio
    Ott, Brian R.
    Peskind, Elaine R.
    Resnick, E. M.
    ANNALS OF NEUROLOGY, 2006, 60 : S6 - S6
  • [42] Efficacy of Memantine on cognition in mild to moderate Alzheimer's disease
    Pomara, N
    Ott, BR
    Peskind, ER
    Resnick, ME
    NEUROLOGY, 2006, 66 (05) : A347 - A348
  • [43] Safety and efficacy of donepezil in African Americans with mild to moderate Alzheimer's disease: A 12-week open-label trial.
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S76 - S76
  • [44] Efficacy of memantine on cognition in mild to moderate Alzheimer's disease
    Pomara, N
    Ott, B
    Peskind, E
    Resnick, M
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 210 - 211
  • [45] Memantine in the treatment of mild-to-moderate Alzheimer's disease
    Cosman, Kelly M.
    Boyle, Llsa L.
    Porsteinsson, Anton P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214
  • [46] An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer's Disease
    Gordon, Marc L.
    Christen, Erica
    Keehlisen, Lynda
    Gong, Michelle
    Lam, Fung
    Giliberto, Luca
    Gomar, Jesus J.
    Koppel, Jeremy
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2024, 8 (01) : 1111 - 1114
  • [47] Rivastigmine and Concomitant Memantine in Alzheimer's Disease: Safety and Tolerability
    Safirstein, Beth
    Meng, Xiangyi
    Olin, Jason T.
    CNS SPECTRUMS, 2010, 15 (09) : 594 - 598
  • [48] Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer's Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan
    Homma, Akira
    Imai, Yukimichi
    Tago, Hisao
    Asada, Takashi
    Shigeta, Masahiro
    Iwamoto, Toshihiko
    Takita, Masashi
    Arimoto, Itaru
    Koma, Hiroshi
    Takase, Takao
    Ohbayashi, Toshio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (03) : 232 - 239
  • [49] Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
    Olin, Jason T.
    Bhatnagar, Vinod
    Reyes, Patricio
    Koumaras, Barbara
    Meng, Xiangyi
    Brannan, Stephen
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 25 (04) : 419 - 426
  • [50] Safety and tolerability of rivastigmine capsules plus memantine in patients with probable Alzheimer's disease
    Brannan, Stephen
    Koumaras, Barbara
    Figiel, Gary
    Farlow, Martin
    ANNALS OF NEUROLOGY, 2008, 64 : S40 - S41
12345